Summary
The immunological findings in Hodgkin’s disease and chronic lymphocytic leukemia are reviewed and described on the basis of the concept of thymus-derived (T) and bone-marrow-derived (B) lymphocytes. Environmental and genetic factors appear to be involved in the pathogenesis of Burkitt lymphoma and Hodgkin’s disease respectively. The pathogenesis of malignant lymphoma in general is discussed on the basis of a recently developed hypothesis.
There is considerable experimental and clinical evidence for the existence of two populations of lymphocytes, a thymus-derived or thymus-dependent (T) population mediating cellular immunity, and a bone marrow-derived (B) population mediating humoral immunity [1]. This concept has proved helpful in the characterization of primary and secondary immune deficiences. Impairment of cell-mediated immunity results in a decreased ability of the organism to express delayed skin reactivity, homograft rejection and defense against viral infections. Defects in humoral immunity are characterized by impairment of antibody production and low levels of one or several classes of immunoglobulins. The purpose of this study is 1) to describe immunological features of malignant lymphomas on the basis of the concept of T and B cells and 2) to collate immunological phenomena with hypotheses for pathogenetic mechanisms of malignant lymphoma.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Roitt, I. M., Greaves, M. F., Torrigiani, G., Brostoff, J., Playfair, J. H. L.: The cellular basis of immunological responses. A synthesis of some current views. Lancet 1969 II, 367.
Aisenberg, A. C.: Manifestations of immunological unresponsiveness in Hodgkin’s Disease. Cancer Res. 26, 1152 (1966).
Brown, R. S., Haynes, H. A., Foley, H. F., Godwin, H. A., Berard, C. W., Carbone, P. P.: Hodgkin’s Disease. Immunologic, clinical and histological features in 50 untreated patients. Ann. intern. Med. 67, 291 (1967).
Young, R. C., Corder, M. P., Haynes, H. A., de Vita, V. T.: Delayed hypersensitivity in Hodgkin’s Disease. A study in 103 untreated patients. Ann. intern. Med. 52, 63 (1972).
Crowther, D., Fairley, G. H., Sewell, R. L.: Significance of changes in the circulating lymphoid cells in Hodgkin’s Disease. Brit. med. J. 1969 II, 473.
Hersh, E. M., Oppenheim, J. J.: Impaired in vitro lymphocyte transformation in Hodgkin’s Disease. New Engl. J. Med. 273, 1006 (1965).
Twomey, J., Douglass, C., Norris, S.: Failure of leucocytes in Hodgkin’s Disease to stimulate a mixed leucocyte reaction (MLR). In: Proc. 7th leucocyte Culture Conference (FRITZ Daguillard, editor). New York: Academic Press 1973.
Müftüoglu, A. ü., Balkuv, S.: Passive transfer of tuberculin sensitivity to patients with Hodgkin’s Disease. New Engl. J. Med. 277, 126 (1967).
Lawrence, H. S.: Transfer factor. Advanc. Immunol. 11, 195 (1969).
Flad, H.-D., Huget, R. P.: Effect of mitogenic factor on lymphocytes from patients with primary and secondary immune deficiencies. Paper presented at the 3rd Meeting of the Gesellschaft für Immunologie. Marburg, 1971.
Order, S. E., Hellmann, S.: Pathogenesis of Hodgkin’s Disease. Lancet 1972 I, 571.
Burnet, F. M.: Immunological surveillance. Elmsford, N. Y.: Pergamon Press 1970.
Hersh, E. M., Guinn, G. A., Rossen, R., Wallace, S., Rose, R., Freireich, E. J.: Two populations of lymphocytes in chronic lymphocytic leukaemia. In: Proc. IV Leukocyte Culture Conference. (Ed.: O. R. Mcintyre.) New York: Appleton Century Crofts 1970.
Flad, H.-D., Huget, R. P., Bremer, K., Bruch, CHR.: TWO populations of lymphocytes in chronic lymphocytic leukaemia (CLL). Europ. J. clin. Invest. 2, 284 (1972).
Bremer, K., Schick, P., Wack, O., Theml, H., Brass, B., Heimpel, H.: Rezirkulation von Lymphozyten bei Patienten mit malignen lymphatischen Erkrankungen. Blut 24, 215 (1972).
Flad, H.-D., Huber, C., Bremer, K., Menne, H. D., Huber, H.: Impaired recirculation of B lymphocytes in chronic lymphocytic leukemia. Europ. J. Immunol. 3, 688 (1973).
Vincent, P. C., Gunz, F. W.: Control of lymphocyte level in the blood. Lancet 1970 II, 342.
Fass, L., Herbermann, R. B., Ziegler, J.: Delayed cutaneous hypersensitivity reactions to autologous extracts of Burkitt lymphoma. New Engl. J. Med. 282, 776 (1970).
Forbes, J. F., Morris, P. J.: Analysis of HL-A antigens in patients with Hodgkin’s Disease and their families. J. clin. Invest. 51, 1156 (1972).
Mcdevitt, H. O., Benacerraf, B.: Genetic control of specific immune responses. Advanc. Immunol. 11, 31 (1969).
Ellman, L., Green, I., Martin, W. J.: Histocompatibility genes, immune responsiveness and leukaemia. Lancet 1970 1, 1104.
Schwartz, R. S.: Immunoregulation. Oncogenic viruses and malignant lymphomas. Lancet 1972 I, 1266.
Penn, J., Hammond, W., Brettschneider, L., Starzl, T. E.: Malignant lymphomas in transplantation recipients. Transplant. Proc. 1, 106 (1969).
Uhr, J. W., Möller, G.: Advanc. Immunol. 8, 81 (1968).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Flad, HD. (1974). Immunology and Immune Reactions in Malignant Lymphoma. In: Musshoff, K. (eds) Diagnosis and Therapy of Malignant Lymphoma. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 46. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80829-6_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-80829-6_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80831-9
Online ISBN: 978-3-642-80829-6
eBook Packages: Springer Book Archive